Skip to main content
Equibles

UBS Group AG

Position in NYXH — Nyxoah SA

CIK 1610520 ZURICH, V8
Back to NYXH Full portfolio

Position in NYXH

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$60,246
+$29,266 QoQ
Shares Held
35,649
+429.3% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 45 holders
Holding Since
Dec 2021
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NYXH Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

UBS Group AG holds $4,686,473,125 across 138 Medical Devices names. NYXH ranks #99 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BSX
Boston Scientific Corp
 16,352,420 $697,921,281
2 ABT
Abbott Laboratories
 7,356,093 $667,491,874
3 SYK
Stryker Corp
 1,909,680 $601,243,647
4 MDT
Medtronic plc
 5,551,443 $434,289,383
5 DXCM
Dexcom Inc
 6,065,779 $408,530,211
6 ZBH
Zimmer Biomet Holdings, Inc.
 2,758,615 $237,489,163
7 PEN
Penumbra Inc
 703,822 $222,231,795
8 EW
Edwards Lifesciences Corp
 2,350,656 $212,640,338

All Filings in NYXH

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $60,246 35,649
2025-12-31 $30,980 6,735
2025-09-30 $24,766 5,384
2025-06-30 $5,168 691
2025-03-31 $85,183 12,204
2024-06-30 $179,686 25,780
2024-03-31 $4,343 322
2023-12-31 $1,067 230
2023-09-30 $1,445 205
2022-12-31 $1,037 208
2022-09-30 $403 64
2022-06-30 $12,870 1,399
2021-12-31 $3,703 161